COMPLETED

Supplementing Brief Psychotherapy With a Mobile App

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after discharge. Even among those who do attend therapy, however, the skills learned in treatment may be difficult to use during the highly distressing time leading up to and during a suicide crisis. Most traditional treatments are not designed to be effective during a suicide crisis. In order to reduce the risk of suicidal thoughts and behaviors in general and specifically during the post-discharge period, interventions are needed that: (1) are easily adhered to and (2) are accessible and effective during a suicide crisis. As such, the purpose of this research study is to test an innovative, new intervention in order to develop an effective and accessible intervention for those at high risk for suicide

Official Title

Supplementing Brief Psychotherapy With a Mobile App

Quick Facts

Study Start:2023-09-14
Study Completion:2024-06-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05867316

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult status (18+ years)
  2. * Admission to eligible units in our partner hospital with a reason for admission having to do with suicide risk
  3. * The ability to speak and write English fluently,
  4. * Ownership of and consistent access to an internet-capable smartphone (e.g., an iPhone or Android phone)
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Evan Kleiman
PRINCIPAL_INVESTIGATOR
Rutgers, The State University of New Jersey

Study Locations (Sites)

Rutgers University Behavioral Healthcare
Piscataway, New Jersey, 08854
United States

Collaborators and Investigators

Sponsor: Rutgers, The State University of New Jersey

  • Evan Kleiman, PRINCIPAL_INVESTIGATOR, Rutgers, The State University of New Jersey

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-14
Study Completion Date2024-06-06

Study Record Updates

Study Start Date2023-09-14
Study Completion Date2024-06-06

Terms related to this study

Keywords Provided by Researchers

  • suicidal ideation
  • suicide attempts

Additional Relevant MeSH Terms

  • Suicide and Self-harm
  • Emotion Regulation